"We believe we now have a device that can treat all these etiologies in a way that we didn't understand before when we were designing, basically, an aneurysm device."

— David Abeyta, leader of the Aortic business unit at W. L. Gore & Associates, discussing the benefits of the company's Conformable Gore TAG device which is undergoing U.S. clinical trials, "Gore in U.S. trials with new Conformable TAG device."